PHYLA Announces a Series of International Collaborations With the University of Bradford and UPM and a Significant Government-Supported Land Regeneration Project in the Gambia
10.12.2024 14:00:00 CET | ACCESS Newswire | Press release
LONDON, UK
PHYLA and the University of Bradford join forces to develop marketable compounds, cosmetics and superfood products from the pongamia plant
PHYLA has entered into a commercial agreement with the University of Bradford to develop marketable bio-compounds for cosmetics and superfood products derived from the pongamia (oil tree) plant which are cultivated in PHYLA's land regeneration projects. The partnership aims to leverage PHYLA's existing IP by applying specific extraction technologies which maximise the yield and value of bio-compounds and other plant-based products.

Phyla's Pongamia Pods
Phyla's high-density pongamia pod cluster
Professor Anant Paradkar, Director of The Centre for Pharmaceutical Engineering Science (CPES) at the University of Bradford, commented:
"We are thrilled to collaborate with PHYLA to advance the development of plant-based products. Our Centre has a long-standing commitment to green and sustainable extraction technologies, and this partnership aligns perfectly with our ethos. The compounds produced by PHYLA's elite pongamia hold immense promise for a range of applications, and we are eager to apply our expertise in pharmaceutical engineering to bring these products to fruition."
PHYLA and UPM collaborate to pilot agroforestry concepts
PHYLA also announces an agreement with UPM to explore the biological and commercial viability of agroforestry concepts. PHYLA and UPM will develop nursery operations in South America for PHYLA's elite species of pongamia. This initiative seeks to explore the potential of the plant for large-scale agroforestry concepts focusing on cultivation, yield and environmental impact. Focus is on exploring pongamia cultivation potential on degraded land, contributing to its long-term productivity and environmental preservation as well as providing additional economic opportunities for farmers and rural communities.
Rabih El Fadel, CEO at PHYLA, expressed his enthusiasm for the partnership:
"We couldn't be more delighted to collaborate with UPM. Their commitment to sustainable practices and innovation is unmatched, and their state-of-the-art facilities and plantation operations will push the boundaries of pongamia agroforestry. We couldn't ask for better partners to achieve our ambitious goals."
PHYLA expands into The Gambia with Presidential and GiEPA Investment Incentive Support
PHYLA continues its expansion into Equatorial Africa with a memorandum of understanding signed with local operator, EcoHub, to build pongamia nurseries and land regeneration projects in The Gambia. EcoHub has been established by local stakeholders, led by Jaha Dukureh (co-founder of Regenerative Hubs, Nobel Peace Prize nominee and UN Women Ambassador for Africa), as PHYLA's local operating partner in The Gambia. Partnering with well-established local agribusiness operators, the regional joint venture aims to scale the production of pongamia saplings for agroforestry projects across the Great Green Wall. The project will generate significant local employment, incorporate educational and certification programs supported by various foundations, and enhance food, energy, and input security regionally.
The project facilitated by the Gambia Investment and Export Promotion Agency (GiEPA) has attracted the President of the Republic of The Gambia, Mr. Adama Barrow to visit the project area in November 2024 during his Meet the People Tour. The President was joined by GiEPA CEO - Ousainou Senghore. During his visit, President Barrow expressed his strong endorsement for the initiative:
"We are pleased to support this project through The Gambia Investment and Export Promotion Agency (GiEPA), which aims to transform unproductive land into thriving and productive landscapes while creating significant amounts of plant oil to boost the local economy. This project not only provides food and energy security but will also help enable sustainable incomes for local farmers and create resilient climate-friendly agricultural and supply chain systems that can be replicated across the country and the wider region."
About PHYLA
PHYLA is a UK company with operations in India and Zambia. It was established in 2021 by its founders after decades developing with their team the elite pongamia tree. This proprietary drought and saline-resistant plant regenerates degraded land and produces a range of valuable products, from SAF feedstock to proteins and natural cosmetics. It is also highly effective in fixing nitrogen in the soil and sequestering carbon. Headquartered in the UK, PHYLA's operations span Sub-Saharan Africa and Asia, with active plans to expand globally to meet increasing demand for land regeneration.
Accredited by the United Nations Convention to Combat Desertification (UNCCD) , PHYLA is dedicated to addressing the global challenge of land degradation, a critical issue affecting over 2 billion hectares worldwide. In response, PHYLA has set an ambitious goal of regenerating at least one million hectares through agroforestry-driven solutions within the next decade. Through its innovative approach, PHYLA is committed to a future where environmental restoration and economic growth go hand in hand, promoting resilient landscapes and sustainable livelihoods.
About Bradford University and CPES
The University of Bradford focuses on creating the conditions for social, cultural and economic impact. With a rich history of making knowledge work, the University's research mission is to drive sustainable social and economic development through outstanding teaching, research and innovation. The CPES is an interdisciplinary research and industrial collaboration centre, which has expertise across the pharmaceutical sciences, chemistry and polymer engineering disciplines with an excellent reputation for contract research and working with industry.
About UPM
UPM employs 16,600 people worldwide with annual sales of approximately €10.5 billion. Its shares are listed on Nasdaq Helsinki Ltd.
UPM responds to the growth in consumer demand with recyclable products that are made of responsibly sourced, renewable raw materials. It delivers responsible solutions and innovates for a future beyond fossils across six business areas: UPM Fibres, UPM Energy, UPM Raflatac, UPM Specialty Papers, UPM Communication Papers and UPM Plywood. As the industry leader in responsibility, it is committed to the UN Business Ambition for 1.5°C and the science-based targets to mitigate climate change.
About GiEPA
The Gambia Investment and Export Promotion Agency (GiEPA) is the national Agency established under a legislative Act of 2010. Its core mandate is to promote and facilitate investment, export and business enterprise development with a key role in policy advocacy to improve the Gambia's business environment.
GiEPA also facilitate both foreign direct investment and domestic direct investment with incentives to entice qualified investments. It also facilitate networking, access to finance and project development to help active private sector participation in national development.
About EcoHub
EcoHub is PHYLA's dedicated local operator in The Gambia, established to spearhead initiatives that combine sustainability, agriculture, and community development. It was co-founded by prominent stakeholders committed to regenerative and sustainable development, including Jaha Dukureh-a Nobel Peace Prize nominee and UN Women Ambassador for Africa; Momarr Taal, the CEO of Ecosoil and Tripingo Foods; and Henry Rowlands, the CEO of Soil In Formation.
The venture will drive innovative agricultural practices and environmental stewardship, focusing on regenerative agriculture and soil health. By collaborating with local communities and leveraging cutting-edge solutions, the venture aims to enhance productivity, improve livelihoods, and promote ecological balance in The Gambia.
Contact Information
AJ Heath
Head of Media, Phyla Earth
aj@phyla.earth
+44 (0) 7733 262 614
Source: Phyla Earth Limited
View the original press release on accesswire.com
Phyla Earth Limited

Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 20265.2.2026 12:00:00 CET | Press release
Datavault AI signed $49M of Tokenization and Technology Licensing agreements in Q4'25 that impact FY2025 and FY2026 Revenue. Revenue: Datavault AI expects at least $30 million in revenue for FY2025, compared to $2.7 million in FY2024. This represents an increase of more than 1,000% growth in our revenue over 2024. The Company continues to expand to drive substantial near- and long-term accretion to our cash flows and earnings with a revenue target for 2026 of at least $200 million. PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / February 5, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the "Company"), a leader in data monetization, credentialing, digital engagement and real-world asset (RWA) tokenization technologies, today issued a letter from Nathaniel Bradley, its Chief Executive Officer, to its stockholders highlighting the Company's accomplishments in 2025 and its outlook for 2026. A MESSAGE FROM OUR CHIEF EXECUTIVE OFFICER Dear Datavault AI Stockholders, I would like t
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release
OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to
Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release
CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom